Published 1 year ago • loading... • Updated 1 year ago
Multiple myeloma patients see hope in newly approved Health Canada drug
Summary
Canada has approved a first-of-its-kind drug for multiple myeloma, a significant advancement in the treatment of a cancer that has no cure, with patients going through repeated cycles of remission and relapse. Myeloma is a cancer of the bone marrow and blood, easily confused by name with melanoma, which is a serious skin disease. The disease forms in plasma cells, which, when healthy, create antibodies that fight infections.